NCT04061148 Near Infrared Spectroscopy (NIRS) for Assessment of Depression
| NCT ID | NCT04061148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Major Depressive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2019-01-04 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2019-01-04 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five visits per subject) comparison of patients being treated for Major Depressive Disorder with control, non-depressed subjects.
Eligibility Criteria
Inclusion Criteria: * All subjects who sign informed consent. * Controls: Volunteers over 18 years of age who are not depressed. * Patients over 18 years of age with a diagnosis of Major Depressive Disorder, receiving clinical therapy at SFVAMC. Exclusion Criteria: * Subjects who cannot sign informed consent. * Exclusion criteria for control subjects: 1.Depression 2.Anxiety, psychotic, substance abuse, mood and personality disorders 3.Major neurocognitive disorders such as Alzheimer's disease and other dementias 4.Neurologic disorders with anatomic lesions including traumatic brain injury, stroke, tumor and arteriovenous malformation * Exclusion criteria for depressed patients: 1.Psychotic disorders like schizophrenia 2.Major neurocognitive disorders such as Alzheimer's disease and other dementias 3.Neurologic disorders with anatomic lesions including traumatic brain injury, stroke, tumor and arteriovenous malformation 4.Not receiving clinical therapy for depression at SFVAMC'
Contact & Investigator
Arthur Wallace, MD, PhD
PRINCIPAL INVESTIGATOR
San Francisco Veterans Affairs Medical Center
Frequently Asked Questions
Who can join the NCT04061148 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04061148 currently recruiting?
Yes, NCT04061148 is actively recruiting participants. Contact the research team at Anusha.Badathala@ncire.org for enrollment information.
Where is the NCT04061148 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT04061148 clinical trial?
NCT04061148 is sponsored by University of California, San Francisco. The principal investigator is Arthur Wallace, MD, PhD at San Francisco Veterans Affairs Medical Center. The trial plans to enroll 90 participants.